GLAUKOS Corp (GKOS) Gross Margin
- Gross margin · 12 months: Value 60.70%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 60.70% | Gross profit / revenue. Period ending 2026-06-30. $372.01M ÷ $612.84M × 100 ≈ 60.70% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 372.01M USD | Gross Profit |
| Revenue | 612.84M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 127.96M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $372.01M | $612.84M | $127.96M | 60.70% |
| 2026-03-31 | $317.64M | $551.35M | $120.84M | 57.61% |
| 2025-12-31 | $282.76M | $507.44M | $111.81M | 55.72% |
| 2025-09-30 | $361.14M | $469.82M | $108.68M | 76.87% |
| 2025-06-30 | $330.52M | $432.95M | $102.43M | 76.34% |
| 2025-03-31 | $306.44M | $404.52M | $98.08M | 75.75% |
| 2024-12-31 | $289.45M | $383.48M | $94.03M | 75.48% |
| 2024-09-30 | $276.06M | $360.35M | $84.28M | 76.61% |
| 2024-06-30 | $261.52M | $341.73M | $80.21M | 76.53% |
| 2024-03-31 | $248.67M | $326.43M | $77.76M | 76.18% |
| 2023-12-31 | $239.14M | $314.71M | $75.58M | 75.99% |
| 2023-09-30 | $229.67M | $303.57M | $73.91M | 75.65% |
| 2023-06-30 | $224.54M | $296.79M | $72.26M | 75.65% |
| 2023-03-31 | $219.09M | $289.08M | $69.99M | 75.79% |
| 2022-12-31 | $213.88M | $282.86M | $68.98M | 75.61% |
| 2022-09-30 | $216.25M | $284.88M | $68.62M | 75.91% |
| 2022-06-30 | $221.19M | $288.32M | $67.13M | 76.72% |
| 2022-03-31 | $226.67M | $293.72M | $67.06M | 77.17% |
| 2021-12-31 | $227.38M | $294.01M | $66.63M | 77.34% |
| 2021-09-30 | $224.65M | $294.00M | $69.35M | 76.41% |
| 2021-06-30 | $212.21M | $284.13M | $71.91M | 74.69% |
| 2021-03-31 | $161.77M | $237.59M | $75.82M | 68.09% |
| 2020-12-31 | $133.24M | $224.96M | $91.72M | 59.23% |
| 2020-09-30 | $129.54M | $217.57M | $88.03M | 59.54% |
| 2020-06-30 | $133.45M | $211.25M | $77.80M | 63.17% |
| 2020-03-31 | $174.29M | $238.29M | $64.01M | 73.14% |
| 2019-12-31 | $198.40M | $236.98M | $38.59M | 83.72% |
| 2019-09-30 | $195.41M | $225.21M | $29.80M | 86.77% |
| 2019-06-30 | $182.50M | $210.61M | $28.11M | 86.65% |
| 2019-03-31 | $168.77M | $195.17M | $26.40M | 86.47% |
| 2018-12-31 | $156.20M | $181.28M | $25.07M | 86.17% |
| 2018-09-30 | $146.26M | $168.85M | (m) | 86.62% |
| 2018-06-30 | $143.06M | $165.36M | (m) | 86.52% |
| 2018-03-31 | $141.82M | $163.48M | (m) | 86.75% |
| 2017-12-31 | $138.20M | $159.25M | (m) | 86.78% |
| 2017-09-30 | $129.54M | $150.78M | (m) | 85.92% |
| 2017-06-30 | $120.54M | $139.94M | (m) | 86.14% |
| 2017-03-31 | $108.98M | $127.21M | (m) | 85.66% |
| 2016-12-31 | $98.22M | $114.40M | (m) | 85.86% |
| 2016-09-30 | $86.54M | $101.50M | (m) | 85.26% |
| 2016-06-30 | $76.53M | $90.93M | (m) | 84.17% |
| 2016-03-31 | $66.81M | $80.13M | (m) | 83.38% |
| 2015-12-31 | $58.71M | $71.70M | (m) | 81.89% |
| 2015-09-30 | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) |
| 2015-03-31 | $39.74M | (m) | (m) | (m) |
| 2014-12-31 | $34.17M | $45.59M | (m) | 74.95% |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) |
| 2013-12-31 | $18.41M | $20.95M | (m) | 87.90% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |